Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-010024
Filing Date
2023-03-03
Accepted
2023-03-03 16:16:03
Documents
1
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3692
  Complete submission text file 0001140361-23-010024.txt   5023
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Issuer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address
O'Kane Kieran (Reporting) CIK: 0001828131 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39659 | Film No.: 23704159